Open AccessDevastadora complicación tras tratamiento con aflibercept
Author(s) -
Estíbaliz EchazarretaGallego,
Manuela Elía-Guedea,
Elena Córdoba-Díaz de Laspra
Publication year - 2016
Publication title -
cirugía y cirujanos
Language(s) - Spanish
Resource type - Journals
SCImago Journal Rank - 0.139
H-Index - 16
eISSN - 2444-054X
pISSN - 0009-7411
DOI - 10.1016/j.circir.2016.03.011
Subject(s) - aflibercept , medicine , chemotherapy , bevacizumab
The use of a new chemotherapy as adjuvant treatment of colorectal cancer is not free of complications. Monoclonal antibodies are associated with bleeding and intestinal perforations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom